Release Date: 28/09/18 09:28 Summary: Appendix 4C (Monthly Reporting) - August 2018 Price Sensitive: Yes Download Document 185.93KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status